Similar articles

• Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.

  Yates T, Haffner SM, Schulte PJ, Thomas L, Huffman KM, Bales CW, Califf RM, Holman RR, McMurray JJ, Bethel MA, Tuomilehto J, Davies MJ, Kraus WE. Yates T, et al. Lancet. 2014 Mar 22;383(9922):1059-66. doi: 10.1016/S0140-6736(13)62061-9. Epub 2013 Dec 20. Lancet. 2014. PMID: 24361242 Clinical Trial.
• International Variation in Outcomes Among People with Cardiovascular Disease or Cardiovascular Risk Factors and Impaired Glucose Tolerance: Insights from the NAVIGATOR Trial.

  Harumi Higuchi Dos Santos M, Sharma A, Sun JL, Pieper K, McMurray JJ, Holman RR, Lopes RD. Harumi Higuchi Dos Santos M, et al. J Am Heart Assoc. 2017 Jan 13;6(1):e003892. doi: 10.1161/JAHA.116.003892. J Am Heart Assoc. 2017. PMID: 28087508 Free PMC article.
• Effects of Nordic walking on cardiovascular risk factors in overweight individuals with type 2 diabetes, impaired or normal glucose tolerance.

  Fritz T, Caidahl K, Krook A, Lundström P, Mashili F, Osler M, Szekeres FL, Östenson CG, Wändell P, Zierath JR. Fritz T, et al. Diabetes Metab Res Rev. 2013 Jan;29(1):25-32. doi: 10.1002/dmrr.2321. Diabetes Metab Res Rev. 2013. PMID: 22887834 Clinical Trial.
• [IGT and risk of cardiovascular disease].

  Kuzuya H, Kono S, Oishi M, Tsujii S. Kuzuya H, et al. Nihon Rinsho. 1997 Nov;55 Suppl:827-32. Nihon Rinsho. 1997. PMID: 9434572 Review. Japanese. No abstract available.
• Glucose and cardiovascular risk.

  Fuchs M, Hoekstra JB, Mudde AH. Fuchs M, et al. Neth J Med. 2002 Jun;60(5):192-9. Neth J Med. 2002. PMID: 12365474 Review.